A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells

被引：0
|
作者：
Dawei Zhao
Di Wu
Gengyue Zhang
Yongqi Li
Weiguo Shi
Bohua Zhong
Hong Yu
机构：
[1] Jilin Cancer Hospital,Department of Breast Tumor
[2] Tumor Center of Jilin University No.1 Hospital,Cell Biology Laboratory
[3] Jilin Province Tumor Institute,undefined
[4] Jilin Cancer Hospital,undefined
[5] Institute of Pharmacology and Toxicology Academy of Military Medical Sciences,undefined
来源：
Molecular Biology Reports | 2022年 / 49卷
关键词：
Irinotecan derivate; CPT-11; SN38; DNA topoisomerase I; Apoptosis; Cell cycle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8359 / 8368
页数：9
相关论文
共 50 条
  • [1] A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells
    Zhao, Dawei
    Wu, Di
    Zhang, Gengyue
    Li, Yongqi
    Shi, Weiguo
    Zhong, Bohua
    Yu, Hong
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (09) : 8359 - 8368
  • [2] Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
    Reita, Damien
    Bour, Cyril
    Benbrika, Radhia
    Groh, Audrey
    Pencreach, Erwan
    Guerin, Eric
    Guenot, Dominique
    CANCERS, 2019, 11 (10)
  • [3] Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
    Motwani, M
    Sirotnak, FM
    She, YH
    Commes, T
    Schwartz, GK
    CANCER RESEARCH, 2002, 62 (14) : 3950 - 3955
  • [4] A radical scavenger enhances anti-tumor effect of CPT-11 in murine colon cancer through increased apoptosis by inhibition of NF-kB.
    Hattori, T
    Kokura, S
    Ishikawa, T
    Higasihara, H
    Sakamoto, N
    Nakabe, N
    Naito, Y
    Yoshida, N
    Yoshikawa, T
    GASTROENTEROLOGY, 2005, 128 (04) : A480 - A480
  • [5] Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma
    Jansen, WJM
    Kolfschoten, GM
    Erkelens, CAM
    VanArkOtte, J
    Pinedo, HM
    Boven, E
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (06) : 891 - 896
  • [6] The efficacy of the bevacizumab in combination with irinotecan(CPT-11) against lung metastasis following removal of orthotopically transplanted human colon cancer in rat
    Mizobe, Tomoaki
    Ogata, Yutaka
    Akagi, Yoshito
    Shirouzu, Kazuo
    CANCER RESEARCH, 2006, 66 (08)
  • [7] The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-κB
    Kokura, S
    Yoshida, N
    Sakamoto, N
    Ishikawa, T
    Takagi, T
    Higashihara, H
    Nakabe, N
    Handa, O
    Naito, Y
    Yoshikawa, T
    CANCER LETTERS, 2005, 229 (02) : 223 - 233
  • [8] CPT-11 mitigates autoimmune diseases by suppressing effector T cells without affecting long-term anti-tumor immunity
    Liang, Hantian
    Fan, Xinzou
    Cheng, Hao
    Ma, Xiao
    Sun, Yutong
    Nan, Fang
    Zhou, Jingyang
    Shu, Panyin
    Zhang, Wei
    Zuo, Fengqiong
    Nakatsukasa, Hiroko
    Zhang, Dunfang
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [9] Inhibition of NF-B and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38
    Chen, Ming-Cheng
    Lee, Nien-Hung
    Hsu, Hsi-Hsien
    Ho, Tsung-Jung
    Tu, Chuan-Chou
    Chen, Ray-Jade
    Lin, Yueh-Min
    Viswanadha, Vijaya Padma
    Kuo, Wei-Wen
    Huang, Chih-Yang
    ENVIRONMENTAL TOXICOLOGY, 2017, 32 (02) : 669 - 678
  • [10] Molecular mechanisms on sequence dependent antitumor efficacy of CPT-11 and 5-fluorouracil combination therapy against colon cancer cells
    Ogata, Yutaka
    Torigoe, Shoujiro
    Matono, Keiko
    Ishibashi, Nobuya
    Shirouzu, Kazuo
    CANCER RESEARCH, 2006, 66 (08)
12345